This study is intended to evaluate the safety and efficacy of Iguratimod in patients with active Rheumatoid Arthritis.

Read more: http://www.clinicaltrials.gov/ct2/show/NCT01554917?cond=%22Arthritis%22&lup_s=10/31/2013&lup_d=30